JPX:4592
SanBio Company Limited · JPX · Healthcare · JPY · FY for 2026
Figures on this page computed 2026-11-07 14:24 UTC
Last close
n/aJPY
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
0.09Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Price is the furthest below its sector's middle: 0.23 against 0.45 on the market's range.
- Growth-33.3%29 of 100, below its sector
- Returns on capital-28.2%23 of 100, above its sector
- Marginsn/anot placed
- Price4.3x23 of 100, below its sector
- Safety0.0989 of 100, above its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
3 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Salesn/a
Its own average over 4 years, 657.2M.
- Profit1.04x
Its own average over 10 years, -3.68B.
- Free cash flow0.84x
Its own average over 10 years, -4.55B.
- Debt0.58x
Its own average over 10 years, 2.14B.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 0.58 times.
The filed years, as a table
10Each line is 100 at 2017-01-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2017-01-31 | 100.0 | 100.0 |
| 2018-01-31 | 51.7 | 101.1 |
| 2019-01-31 | 78.1 | 108.1 |
| 2020-01-31 | 47.1 | 113.9 |
| 2021-01-31 | n/a | 115.4 |
| 2022-01-31 | n/a | 115.4 |
| 2023-01-31 | n/a | 129.0 |
| 2024-01-31 | n/a | 145.5 |
| 2025-01-31 | n/a | 153.4 |
| 2026-01-31 | n/a | 162.9 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- JPY
Figures behind the shape
Growth
-33.3%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
One-year change in net income-33.3%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Returns on capital
-28.2%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equity-28.2%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets-24.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
n/aWe do not hold this figure for this company, so there is nothing to place.
wider is higher, with no cohort held
Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating marginn/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Net marginn/a
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow marginn/a
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
4.3xcheaper is higher, placed against 4,482 companies as of 2026-11-06
Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
Price to book4.3x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ration/a
We do not hold this figure for this company, so there is nothing to place.
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
0.09safer is higher, placed against 4,231 companies as of 2026-11-06
Debt to equity0.09
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio28.99
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Scoren/a
We do not hold this figure for this company, so there is nothing to place.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- JPY
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.